Chronic kidney disease symptoms like blood in urine, swollen joints, foamy urine, etc are seldom noticed by patients resulting in progressive loss of kidney functions and ultimately renal failure. Delayed diagnosis, lack of sufficient epidemiological data, the significant cost involved in end-stage renal diseases as well as mild kidney diseases have resulted in a substantial need for chronic kidney disease diagnostics. Apart from physical examination by healthcare professionals, certain diagnostics like biopsy or procedures like blood and urine test provide vital stats and early signs about patients neurological, blood vessels and organ conditions. Based on such diagnostic results healthcare professionals can effectively control the kidney symptoms and avoid the progression of chronic kidney disease in their patients.
Factors boosting the chronic kidney disease diagnostics market:
- Rising prevalence of kidney diseases
- Increase in diabetic patients’ population
- Investments into R D for kidney diseases diagnostic techniques
- The ever-emerging healthcare sector
- Extensive use of processed food containing excess potassium and
- The technological advancements in the healthcare diagnostics sector
Besides increased susceptibility of the ageing population due to degrading immune system, diabetics, cardiovascular issues are expected to fuel the growth of the global chronic kidney diseases diagnostics market during the forecast period.
North America holds the major revenue chunk in the global kidney diseases diagnostics market. This is followed by Europe due to robust economic growth and investments in advanced diagnostic technologies. India, China and Vietnam from the APAC region are expected to demonstrate tremendous opportunities due to increased healthcare awareness, better household incomes and government aids to healthcare institutions. Rest of the world is expected to grow at a gradual CAGR and considerable market value in coming years.